Abstract

In the Firmicutes phylum, GpsB is a membrane associated protein that coordinates peptidoglycan synthesis with cell growth and division. Although GpsB has been studied in several bacteria, the structure, function, and interactome of Staphylococcus aureus GpsB is largely uncharacterized. To address this knowledge gap, we solved the crystal structure of the N-terminal domain of S. aureus GpsB, which adopts an atypical, asymmetric dimer, and demonstrates major conformational flexibility that can be mapped to a hinge region formed by a three-residue insertion exclusive to Staphylococci. When this three-residue insertion is excised, its thermal stability increases, and the mutant no longer produces a previously reported lethal phenotype when overexpressed in Bacillus subtilis. In S. aureus, we show that these hinge mutants are less functional and speculate that the conformational flexibility imparted by the hinge region may serve as a dynamic switch to finetune the function of the GpsB complex and/or to promote interaction with its various partners. Furthermore, we provide the first biochemical, biophysical, and crystallographic evidence that the N-terminal domain of GpsB binds not only PBP4, but also FtsZ, through a conserved recognition motif located on their C-termini, thus coupling peptidoglycan synthesis to cell division. Taken together, the unique structure of S. aureus GpsB and its direct interaction with FtsZ/PBP4 provide deeper insight into the central role of GpsB in S. aureus cell division.

Data availability

All crystal structures have been deposited in the RCSB Protein Data Bank (PDB) with accession IDs of: Sa GpsB NTD (PDB ID 8E2B), Sa GpsB NTD + Sa PBP4 C-term (PDB ID 8E2C).

The following data sets were generated

Article and author information

Author details

  1. Michael D Sacco

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Lauren R Hammond

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Radwan E Noor

    Global and Planetary Health, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dipanwita Bhattacharya

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Lily J McKnight

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jesper J Madsen

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1411-9080
  7. Xiujun Zhang

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Shane G Butler

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. M Trent Kemp

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Aiden C Jaskolka-Brown

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Sebastian J Khan

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ioannis Gelis

    Department of Chemistry, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Prahathees Eswara

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    For correspondence
    eswara@usf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4430-261X
  14. Yu Chen

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    For correspondence
    ychen1@usf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5115-3600

Funding

National Institutes of Health (R21 AI164775)

  • Yu Chen

National Institutes of Health (R35 GM133617)

  • Prahathees Eswara

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jie Xiao, Johns Hopkins University, United States

Version history

  1. Preprint posted: October 25, 2022 (view preprint)
  2. Received: December 14, 2022
  3. Accepted: April 15, 2024
  4. Accepted Manuscript published: April 19, 2024 (version 1)
  5. Version of Record published: May 1, 2024 (version 2)

Copyright

© 2024, Sacco et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 694
    views
  • 136
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael D Sacco
  2. Lauren R Hammond
  3. Radwan E Noor
  4. Dipanwita Bhattacharya
  5. Lily J McKnight
  6. Jesper J Madsen
  7. Xiujun Zhang
  8. Shane G Butler
  9. M Trent Kemp
  10. Aiden C Jaskolka-Brown
  11. Sebastian J Khan
  12. Ioannis Gelis
  13. Prahathees Eswara
  14. Yu Chen
(2024)
Staphylococcus aureus FtsZ and PBP4 bind to the conformationally dynamic N-terminal domain of GpsB
eLife 13:e85579.
https://doi.org/10.7554/eLife.85579

Share this article

https://doi.org/10.7554/eLife.85579

Further reading

    1. Microbiology and Infectious Disease
    Brian G Vassallo, Noemie Scheidel ... Dennis H Kim
    Research Article

    The microbiota is a key determinant of the physiology and immunity of animal hosts. The factors governing the transmissibility of viruses between susceptible hosts are incompletely understood. Bacteria serve as food for Caenorhabditis elegans and represent an integral part of the natural environment of C. elegans. We determined the effects of bacteria isolated with C. elegans from its natural environment on the transmission of Orsay virus in C. elegans using quantitative virus transmission and host susceptibility assays. We observed that Ochrobactrum species promoted Orsay virus transmission, whereas Pseudomonas lurida MYb11 attenuated virus transmission relative to the standard laboratory bacterial food Escherichia coli OP50. We found that pathogenic Pseudomonas aeruginosa strains PA01 and PA14 further attenuated virus transmission. We determined that the amount of Orsay virus required to infect 50% of a C. elegans population on P. lurida MYb11 compared with Ochrobactrum vermis MYb71 was dramatically increased, over three orders of magnitude. Host susceptibility was attenuated even further in the presence of P. aeruginosa PA14. Genetic analysis of the determinants of P. aeruginosa required for attenuation of C. elegans susceptibility to Orsay virus infection revealed a role for regulators of quorum sensing. Our data suggest that distinct constituents of the C. elegans microbiota and potential pathogens can have widely divergent effects on Orsay virus transmission, such that associated bacteria can effectively determine host susceptibility versus resistance to viral infection. Our study provides quantitative evidence for a critical role for tripartite host-virus-bacteria interactions in determining the transmissibility of viruses among susceptible hosts.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Carlo Giannangelo, Matthew P Challis ... Darren J Creek
    Research Article

    New antimalarial drug candidates that act via novel mechanisms are urgently needed to combat malaria drug resistance. Here, we describe the multi-omic chemical validation of Plasmodium M1 alanyl metalloaminopeptidase as an attractive drug target using the selective inhibitor, MIPS2673. MIPS2673 demonstrated potent inhibition of recombinant Plasmodium falciparum (PfA-M1) and Plasmodium vivax (PvA-M1) M1 metalloaminopeptidases, with selectivity over other Plasmodium and human aminopeptidases, and displayed excellent in vitro antimalarial activity with no significant host cytotoxicity. Orthogonal label-free chemoproteomic methods based on thermal stability and limited proteolysis of whole parasite lysates revealed that MIPS2673 solely targets PfA-M1 in parasites, with limited proteolysis also enabling estimation of the binding site on PfA-M1 to within ~5 Å of that determined by X-ray crystallography. Finally, functional investigation by untargeted metabolomics demonstrated that MIPS2673 inhibits the key role of PfA-M1 in haemoglobin digestion. Combined, our unbiased multi-omic target deconvolution methods confirmed the on-target activity of MIPS2673, and validated selective inhibition of M1 alanyl metalloaminopeptidase as a promising antimalarial strategy.